Search results
Is Pfizer Stock A Sell As Shares Hit An 11-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 4 days agoThis is part of an ongoing final-phase study in the Northern and Southern hemispheres. That's a drop...
FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia
Benzinga via Yahoo Finance· 1 day agoFriday, the FDA approved Pfizer Inc’s (NYSE:PFE) Beqvez (fidanacogene elaparvovec-dzkt) for moderate...
3 Dividend Stocks to Buy and Hold for the Next Decade
Motley Fool via Yahoo Finance· 20 hours agoThe company still has another big hurdle to jump, though, with multiple blockbuster drugs losing...
Pfizer hemophilia gene therapy arrives in US to uncertain future
BioPharma Dive via Yahoo Finance· 2 days agoBeqvez is currently under review in Europe. Pfizer also has an antibody drug for hemophilia A and B...
FDA approves Pfizer's first gene therapy for rare inherited bleeding disorder
NBC Philadelphia· 2 days agoThe Food and Drug Administration approved Pfizer's treatment for a rare genetic bleeding disorder,...
EU regulators approve Pfizer antibiotic Emblaveo (NYSE:PFE)
Seeking Alpha· 6 days agoEU regulators have approved Pfizer (PFE) and AbbVie’s (ABBV) antibiotic product Emblaveo for the...
Pfizer (PFE) Scheduled to Post Quarterly Earnings on Wednesday
ETF DAILY NEWS· 4 days agoPfizer (NYSE:PFE – Get Free Report) is scheduled to issue its quarterly earnings data before the market opens on Wednesday, May 1st. Pfizer has set its ...
A Big Week For The Stock Market: Apple, Amazon, Big Pharma And The Fed
Investor's Business Daily· 1 day agoAs April heads for its last couple of trading days, and the first-quarter earnings season moves past...
FDA Approves Second Gene Therapy for Hemophilia B
Medscape· 2 days agoPfizer reported a list price of $3.5 million for its new gene therapy, Beqvez, for adults with this rare bleeding disorder.
Moderna, Pfizer/BioNTech set for UK court clash over COVID jab patents
Medical Xpress· 5 days agoA row between pharmaceutical firms Moderna and Pfizer/BioNTech comes to court in London on Tuesday...